During the past decade, Arizona Oncology Associates, PC - HAL conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Oncology Associates, PC - HAL" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Seagen Inc." with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Pharmacyclics LLC." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Oncology Associates, PC - HAL" #1 collaborator was "Janssen, LP" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Oncology Associates, PC - HAL" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Urologic Neoplasms" (2 trials), "Biliary Tract Neoplasms" (1 trials), "Carcinoma, Transitional Cell" (1 trials) and "Chronic Lymphocytic Leukemia (CLL)" (1 trials). Many other conditions were trialed in "Arizona Oncology Associates, PC - HAL" in a lesser frequency.

Most popular intervention types in "Arizona Oncology Associates, PC - HAL" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (2 trials), "Placebo" (2 trials), "Amivantamab" (1 trials), "Brentuximab vedotin" (1 trials) and "Daratumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Oncology Associates, PC - HAL" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Arizona Oncology Associates, PC - HAL". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Arizona Oncology Associates, PC - HAL, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Oncology Associates, PC - HAL, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".